CSL Ltd Annual Report 2019

Building Collaborative Partnerships Sometimes delivering innovation requires strategic partnerships to help discover treatment options for the patients we serve. It certainly means investing in the next generation of biomedical researchers before they graduate to ensure we grow our talent pipeline. Our scientists often work alongside people whomay or may not be located in their country or time zone or even their company. Some of our scientists are even co-located with academic researchers. For example, our global hub for Research and Translational Medicine is located at the University of Melbourne in Australia, where our scientists work side-by-side and exchange ideas with their academic counterparts. In the past year alone, we’ve entered exciting research collaborations and made significant investments in the future from Bern, Switzerland, to Philadelphia, United States (US), which you will read about in this report. Ensuring Sustainable Growth As our business grows and the competitive landscape changes, we are adjusting our operating model to ensure we continue to lead from a position of strength. We have long embraced a strategy that provides us the framework to further advance our sustainable growth and, most importantly, continue improving people’s quality of life and protecting public health across the globe. As part of this transformation, enhancing our digital capabilities is one area we are focused on. We recognise this capability as a critical element to the delivery of quality medicines into the future and are committed to transforming our business model to realise opportunity for our stakeholders and patients. Upholding Our Values and Culture For CSL to continue to grow, make a difference in people’s lives through our science and be a highly desirable workplace, we ensure that our values remain the foundation of our culture and the guide for how we work. This reporting period was a year in which stakeholders took notice of our values-based culture. We are proud of the external recognition our talented people and innovative workplace have earned, including (to name a few) Top 100 Most Diverse & Inclusive Organizations Globally (Thomson Reuters), Most Attractive Employers in Switzerland (Universum), and America’s Best Large Employers (Forbes). For us, it’s not about the accolades, but rather knowing that working at CSL offers both meaningful and promising careers to our colleagues. This is an exciting time to be part of CSL as we write our next chapter. We are humbled and honoured to continue to serve patients in our roles as Chairman and Chief Executive Officer respectively. We thank you for your support. Dr Brian McNamee AO, Chairman Paul Perreault, CEO and Managing Director More on CSL.com (Investors > Financial Results and Information) CSL Limited Annual Report 2019 3